Michael A Johansson1, Pedro F C Vasconcelos2, J Erin Staples3. 1. Division of Vector-Borne Diseases, Centers for Disease Control & Prevention, Fort Collins, Colorado, USA mjohansson@cdc.gov. 2. Instituto Evandro Chagas, Department of Arbovirology and Hemorrhagic Fevers, Ministry of Health, Ananindeua, Pará State, Brazil. 3. Division of Vector-Borne Diseases, Centers for Disease Control & Prevention, Fort Collins, Colorado, USA.
Abstract
BACKGROUND: Like many infectious agents, yellow fever (YF) virus only causes disease in a proportion of individuals it infects and severe illness only represents the tip of the iceberg relative to the total number of infections, the more critical factor for virus transmission. METHODS: We compiled data on asymptomatic infections, mild disease, severe disease (fever with jaundice or hemorrhagic symptoms) and fatalities from 11 studies in Africa and South America between 1969 and 2011. We used a Bayesian model to estimate the probability of each infection outcome. RESULTS: For YF virus infections, the probability of being asymptomatic was 0.55 (95% credible interval [CI] 0.37-0.74), mild disease 0.33 (95% CI 0.13-0.52) and severe disease 0.12 (95% CI 0.05-0.26). The probability of death for people experiencing severe disease was 0.47 (95% CI 0.31-0.62). CONCLUSIONS: In outbreak situations where only severe cases may initially be detected, we estimated that there may be between one and seventy infections that are either asymptomatic or cause mild disease for every severe case identified. As it is generally only the most severe cases that are recognized and reported, these estimates will help improve the understanding of the burden of disease and the estimation of the potential risk of spread during YF outbreaks. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND: Like many infectious agents, yellow fever (YF) virus only causes disease in a proportion of individuals it infects and severe illness only represents the tip of the iceberg relative to the total number of infections, the more critical factor for virus transmission. METHODS: We compiled data on asymptomatic infections, mild disease, severe disease (fever with jaundice or hemorrhagic symptoms) and fatalities from 11 studies in Africa and South America between 1969 and 2011. We used a Bayesian model to estimate the probability of each infection outcome. RESULTS: For YF virus infections, the probability of being asymptomatic was 0.55 (95% credible interval [CI] 0.37-0.74), mild disease 0.33 (95% CI 0.13-0.52) and severe disease 0.12 (95% CI 0.05-0.26). The probability of death for people experiencing severe disease was 0.47 (95% CI 0.31-0.62). CONCLUSIONS: In outbreak situations where only severe cases may initially be detected, we estimated that there may be between one and seventy infections that are either asymptomatic or cause mild disease for every severe case identified. As it is generally only the most severe cases that are recognized and reported, these estimates will help improve the understanding of the burden of disease and the estimation of the potential risk of spread during YF outbreaks. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Entities:
Keywords:
Case fatality rate; Epidemiology; Flavivirus; Yellow fever
Authors: D Nash; F Mostashari; A Fine; J Miller; D O'Leary; K Murray; A Huang; A Rosenberg; A Greenberg; M Sherman; S Wong; M Layton Journal: N Engl J Med Date: 2001-06-14 Impact factor: 91.245
Authors: D E Carey; G E Kemp; J M Troup; H A White; E A Smith; R F Addy; A L Fom; J Pifer; E M Jones; P Brès; R E Shope Journal: Bull World Health Organ Date: 1972 Impact factor: 9.408
Authors: K M De Cock; T P Monath; A Nasidi; P M Tukei; J Enriquez; P Lichfield; R B Craven; A Fabiyi; B C Okafor; C Ravaonjanahary Journal: Lancet Date: 1988-03-19 Impact factor: 79.321
Authors: P F Vasconcelos; Z G Costa; E S Travassos Da Rosa; E Luna; S G Rodrigues; V L Barros; J P Dias; H A Monteiro; O F Oliva; H B Vasconcelos; R C Oliveira; M R Sousa; J Barbosa Da Silva; A C Cruz; E C Martins; J F Travassos Da Rosa Journal: J Med Virol Date: 2001-11 Impact factor: 2.327
Authors: A Nasidi; T P Monath; K DeCock; O Tomori; R Cordellier; O D Olaleye; T O Harry; J A Adeniyi; A O Sorungbe; A O Ajose-Coker Journal: Trans R Soc Trop Med Hyg Date: 1989 May-Jun Impact factor: 2.184
Authors: F P Pinheiro; A P Travassos da Rosa; M A Moraes; J C Almeida Neto; S Camargo; J P Filgueiras Journal: Am J Trop Med Hyg Date: 1978-01 Impact factor: 2.345
Authors: T P Monath; R B Craven; A Adjukiewicz; M Germain; D B Francy; L Ferrara; E M Samba; H N'Jie; K Cham; S A Fitzgerald; P H Crippen; D I Simpson; E T Bowen; A Fabiyi; J J Salaun Journal: Am J Trop Med Hyg Date: 1980-09 Impact factor: 2.345
Authors: Ana Freitas Ribeiro; Roberta Figueiredo Cavalin; Jamal Muhamad Abdul Hamid Suleiman; Jessica Alves da Costa; Marileide Januaria de Vasconcelos; Ceila Maria Sant'Ana Málaque; Jaques Sztajnbok Journal: Am J Trop Med Hyg Date: 2019-07 Impact factor: 2.345
Authors: Marco A B de Almeida; Edmilson Dos Santos; Jáder da C Cardoso; Lucas G da Silva; Rafael M Rabelo; Júlio César Bicca-Marques Journal: Ecohealth Date: 2018-12-17 Impact factor: 3.184
Authors: Nicole P Lindsey; Kalanthe A Horiuchi; Corey Fulton; Amanda J Panella; Olga I Kosoy; Jason O Velez; Elizabeth R Krow-Lucal; Marc Fischer; J Erin Staples Journal: J Travel Med Date: 2018-01-01 Impact factor: 8.490
Authors: Patrick K Mitchell; Luis Mier-Y-Teran-Romero; Brad J Biggerstaff; Mark J Delorey; Maite Aubry; Van-Mai Cao-Lormeau; Matthew J Lozier; Simon Cauchemez; Michael A Johansson Journal: Am J Epidemiol Date: 2019-01-01 Impact factor: 4.897
Authors: Jaspreet Toor; Susy Echeverria-Londono; Xiang Li; Kaja Abbas; Emily D Carter; Hannah E Clapham; Andrew Clark; Margaret J de Villiers; Kirsten Eilertson; Matthew Ferrari; Ivane Gamkrelidze; Timothy B Hallett; Wes R Hinsley; Daniel Hogan; John H Huber; Michael L Jackson; Kevin Jean; Mark Jit; Andromachi Karachaliou; Petra Klepac; Alicia Kraay; Justin Lessler; Xi Li; Benjamin A Lopman; Tewodaj Mengistu; C Jessica E Metcalf; Sean M Moore; Shevanthi Nayagam; Timos Papadopoulos; T Alex Perkins; Allison Portnoy; Homie Razavi; Devin Razavi-Shearer; Stephen Resch; Colin Sanderson; Steven Sweet; Yvonne Tam; Hira Tanvir; Quan Tran Minh; Caroline L Trotter; Shaun A Truelove; Emilia Vynnycky; Neff Walker; Amy Winter; Kim Woodruff; Neil M Ferguson; Katy Am Gaythorpe Journal: Elife Date: 2021-07-13 Impact factor: 8.140
Authors: Katy Am Gaythorpe; Kaja Abbas; John Huber; Andromachi Karachaliou; Niket Thakkar; Matthew Ferrari; Michael L Jackson; Kevin McCarthy; T Alex Perkins; Caroline Trotter; Mark Jit; Kim Woodruff; Xiang Li; Susy Echeverria-Londono Journal: Elife Date: 2021-06-24 Impact factor: 8.140